Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02877784 · ClinicalTrials.gov registry record
Screening in Oculopharyngeal Muscular Dystrophy
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 8
- Enrollment target
NCT02877784 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 8 participants.
The verdict
NCT02877784 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
Study Summary
Oculopharyngeal muscular dystrophy (OPMD) is a rare myopathic disease that results in progressive degeneration of the oral and pharyngeal muscular, resulting in severe dysphagia and dysarthria. OPMD is considered a rare disease; therefore, limited research is available on the natural progression of the disease or the utility of biomarkers to identify swallowing impairment. The aim of this study is: 1. To identify accurate, reliable and non-invasive clinical markers of swallowing impairment 2. To determine the discriminate ability of these markers to identify impairments in swallow safety and swallowing efficiency.
Interventions
- PROCEDURE Videofluoroscopic swallowing study
- OTHER Functional Oral Intake Scale
- OTHER Eating Assessment Tool-10
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2016-10 |
| Est. Completion | 2017-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02877784
The ClinicalTrials.gov registry entry for NCT02877784 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Videofluoroscopic swallowing study is the first listed.
NCT02877784 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02877784 about?
NCT02877784 is a clinical study titled "Screening in Oculopharyngeal Muscular Dystrophy". Oculopharyngeal muscular dystrophy (OPMD) is a rare myopathic disease that results in progressive degeneration of the oral and pharyngeal muscular, resulting in severe dysphagia and dysarthria. OPMD is considered a rare disease; therefore, limited research is available on the natural progression of ...
What is the current status of trial NCT02877784?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2016-10. Estimated completion is 2017-08.
What interventions are being tested in trial NCT02877784?
The interventions under investigation include: Videofluoroscopic swallowing study (PROCEDURE), Functional Oral Intake Scale (OTHER), Eating Assessment Tool-10 (OTHER).
Who is sponsoring clinical trial NCT02877784?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.